Related Image: Apple enthusiasts welcome WineCrisp |
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-FirstCall...nnounced that the U.S. Food and Drug Administratio...Company,s amended Biologics License Application (B...e response. The FDA has assigned a Prescription D...hich time it will respond to Dendreon,s amended BL...
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewsw...that the European Investment Fund (EIF) has entere... The co-investment fund will be,managed by Karolin...s,portfolio of early-stage pharmaceutical and medi... 26.7 M Euros in the co-investment fund. The agree...
(Date:11/20/2009)... METTLER TOLEDO recently ...ctions Process Optimization Using At-Line Particle...ember 2, 2009. In this webinar, the application o...d to map the design space and optimize a series of...s, flow rates, and roller compaction forces. , ...
(Date:11/19/2009)... , Most people would like to be able to charge th...ckly and not too often. A recent discovery made by...ube-based supercapacitors that could do just this....ysics Letters , Prabhakar Bandaru, a professor in ...gineering, along with graduate student Mark Hoefer...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2...research may have come up with an explanation as t...d rocks. This explanation could turn out to be the...production techniques with the intent of increasin...arch group at the Nano-Science Center, part of the...n has investigated drill cores collected from Nort...
..., May 11 Sanofi-aventis U.S. announced today that...ma plc the U.S. commercial rights to Oforta(TM) (f... B-cell chronic lymphocytic leukemia (CLL) drug. ... for use as a second-line therapy to treat adults ...to add Oforta to our existing oncology portfolio, ...
...May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a clin...covering, developing, and commercializing novel dr...results and operational highlights for the fiscal ...ults , , Revenues were $1.9 million during the q...on for the quarter ended March 31, 2008 and reflec...
Other Biology Technology:New Danish research shows how oil gets stuck underground 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 85X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
...llow crystalline solid. PROTECT FROM LIGHT. Useful...response data are not required. Purity: ≥98% b...us systems, preparation of a 10 mM stock in DMSO i... can be added to H 2 O with rapid mixing (e.g. 10 ...
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
Mouse Anti-Rhodopsin Monoclonal Antibody, Unconjugated, Clone RET-P1 from GeneTex
Biology Products: